Removing dosing guidance from a guideline summary takes a valuable tool from prescribers, says Dr. Mark Sullivan and pain-medicine colleagues.
The FDA should amend its buprenorphine dose limit, which is outdated, according to a recent literature review.
Seattle investigators will coordinate the American Heart Association's $20 million initiative to improve care for millions.
Narcan, a brand-name prescription nasal spray effective at reversing opioid overdoses, can be sold over the counter, the Food and Drug Administration decided today. Narcan’s active agent is naloxone.
Researchers will explore the ability of Black and Latinx patients to get the less-stigmatized treatment drug, buprenorphine.
In Washington state, 42% of respondents said they had used the dangerous opioid in the previous 3 months.
New pain-treatment guidelines proposed by the Centers for Disease Control and Pre
Overdose death rates with the drug are similar for those under and over 30 – a break from patterns involving heroin and prescribed opioids.
Researchers develop a prototype device that can recognize respiration patterns and administer naloxone, a potential antidote.
Injury-prevention and addiction specialists at UW Medicine collaborate to produce a web tool for teens and parents.
